Company Overview
TG THERAPEUTICS, INC.
TGTXRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
616M
2025 FY
Net Income
447M
2025 FY
Shares Outstanding
144M
2025 FY
EPS
3.1USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1001316
Exchange
Nasdaq
Location
US